Amanta Healthcare Announces Financial Results and Policy Changes Following Board Meeting
Amanta Healthcare Limited announced the outcome of its Board of Directors meeting held on May 19, 2026. The board considered and approved the financial results for the quarter and year ended March 31, 2026. The statutory auditors, Price Waterhouse Chartered Accountants LLP, confirmed that the financial results (standalone) for the quarter and year ended March 31, 2026, were issued with an unmodified opinion.The Board also approved revisions and changes to two key policies: the Code of Conduct for Prevention of Insider Trading and the Whistle Blower Policy.
Financial Performance Overview
The audited financial results for the quarter and year ended March 31, 2026, provide a detailed look at the company's financial performance compared to the previous year.The following table summarizes the key financial data (in Rs. lakhs):
| Particulars | Qtr ended 31.03.2026 (Audited) | Qtr ended 31.12.2025 (Un-audited) | Qtr ended 31.03.2025 (N/A) | Year ended 31.03.2026 (Audited) | Year ended 31.03.2025 (Audited) |
|---|---|---|---|---|---|
| Revenue from operations | 7,699.49 | 7,448.74 | 7,206.28 | 28,767.67 | 27,470.82 |
| Other income | 166.21 | 67.70 | 16.20 | 337.07 | 138.52 |
| Total income | 7,865.70 | 7,516.44 | 7,222.48 | 29,104.74 | 27,609.34 |
| Total expenses | 7,104.03 | 6,886.08 | 6,407.45 | 26,729.39 | 26,138.65 |
| Profit before tax | 761.67 | 630.36 | 815.03 | 2,112.47 | 1,470.69 |
| Total tax expenses | 208.51 | 167.47 | 219.10 | 624.95 | 420.62 |
| Profit for the period/year | 553.16 | 462.89 | 595.93 | 1,487.52 | 1,050.07 |
| Total comprehensive income | 511.01 | 452.85 | 580.47 | 1,415.27 | 1,009.95 |
The company reported a Total comprehensive income of 1,415.27 Rs. lakhs for the year ended March 31, 2026, up from 1,009.95 Rs. lakhs in the previous year. The earnings per share for the year ended March 31, 2026, was 4.33 Rs.
Financial Position and Cash Flow
The Statement of Assets and Liabilities as of March 31, 2026, showed a total asset value of 55,798.07 Rs. lakhs, compared to 38,175.85 Rs. lakhs recorded on the same date in the previous year.Key components of the balance sheet include:
- Non-Current Assets: Increased to 31,945.33 Rs. lakhs (from 24,383.93 Rs. lakhs).
- Current Assets: Totaled 23,852.74 Rs. lakhs (up from 13,791.92 Rs. lakhs).
- Total Assets: Reached 55,798.07 Rs. lakhs.
- Equity: The total equity stood at 20,920.90 Rs. lakhs, comprising Equity Share Capital of 3,882.94 Rs. lakhs and Other Equity of 18,138.16 Rs. lakhs.
- Total Equity and Liabilities: Remained balanced at 55,798.07 Rs. lakhs.
The company's cash flow analysis indicates strong operational generation and investment activity:
| Category | Year ended March 31, 2026 (Audited) | Year ended March 31, 2025 (Audited) |
|---|---|---|
| Cash generated from operations | 5,550.36 | 5,042.00 |
| Net cash from operating activities | 4,844.64 | 4,662.00 |
| Net cash used in investing activities | (9,360.89) | (2,447.25) |
| Net cash from financing activities | 12,595.22 | (2,346.63) |
| Net increase/(decrease) in cash and cash equivalents | 8,078.97 | (131.88) |
| Cash and cash equivalents as at end of the year | 8,101.03 | 22.06 |
Operational Highlights and IPO Utilization
The company continues to operate in a single reportable segment: Manufacturing and sale of pharmaceutical products, which includes contract manufacturing services.During the quarter ended September 30, 2025, the company completed its Initial Public Offer (IPO), issuing 10,000,000 equity shares of face value Rs. 10 each at a price of Rs. 126 per share. This fresh issue aggregated 12,600 lakhs, making the company a listed entity on BSE Limited and the National Stock Exchange of India Limited on September 09, 2025.
The financial results reflect the utilization of IPO proceeds. Specifically, issue expenses of 1,719.16 lakhs (net of GST), allocated for the issue of new shares, were adjusted against the securities premium. Additionally, the cost of 262.88 lakhs (net of GST) allocated for listing of existing shares was recognized as an exceptional item.
Policy Updates
The Board of Directors also approved revisions and changes to the following corporate policies:- Code of Conduct for Prevention of Insider Trading.
- Whistle Blower Policy.
AMANTA Stock Price Movement
Today, Amanta Healthcare Limited shares edged higher, settling at ₹132 after rallying by 4.91% in early trading. The stock saw total trading volume reach 101,401 shares as investors reacted to positive market momentum.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: